SCHEMBL19851219

SCHEMBL19851219

CNC(=S)Nc1ccc(CNS)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
SMN1; SMN2 Q16637 4/20 0.53
MAPT P10636 4/20 0.53
GAA P10253 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HPGD P15428 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 1/20 0.49
RAB9A P51151 1/20 0.49
LMNA P02545 2/20 0.46
ALOX12 P18054 1/20 0.46
HTT P42858 1/20 0.46
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ATM Q13315 1/20 0.44
LSS P48449 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851224 0.87 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL19851240 0.84 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL17469336 0.81 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL19997538 0.81 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL8867893 0.78 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL3976381 0.76 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL8867884 0.76 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL2590098 0.74 CYP1A2 (0.64) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL5078028 0.74 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2MAPTGAACYP1A2
SCHEMBL11550071 0.74 MAPT (0.67) ALDH1A1SMN1; SMN2MAPTGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026538-A1 NOVEL SCAFFOLDS FOR INTRACELLULAR COMPOUND DELIVERY FOR THE DETECTION OF CANCER CELLS ISI Life Sciences Inc. (US) 2018-02-08 WO disclosed